Computer-assisted Fetal Monitoring - Cardiology
SURFAO-CARDIO
1 other identifier
interventional
20
1 country
1
Brief Summary
In the context of fetal heart monitoring (prenatal and during childbirth), the SurFAO project offers an alternative to current clinical routines. The challenge is to extract, from non-invasive sensors on the maternal abdomen, a fetal electrocardiogram (ECGf) of great quality allowing a clinical diagnosis (follow-up of the FHR (Fetal Heart Rate)) and extraction of ECG waveforms). The approach proposes a technological breakthrough shared by a consortium of researchers and clinicians. The originality is driven by innovative methodological choices: the use of a multimodal system (ECG coupling with PCG (phonocardiography)) for the signal acquisition in order to increase the robustness of information extraction, by taking into account clinical uses and the need to support the monitoring process, and by setting up a multimodal database. The objective is to feed a database that will be used in the future to develop ECGf extraction methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2020
CompletedFirst Posted
Study publicly available on registry
January 21, 2020
CompletedStudy Start
First participant enrolled
August 31, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedSeptember 23, 2020
September 1, 2020
1.3 years
January 7, 2020
September 20, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ECG / PCG Signals database
Synchronized signals from ECG electrodes and PCG sensors. Signals will be processed to extract fetal ECG and specific waveforms characteristics of fECG (in parts of R waves, P waves, QT intervals, ST intervals).
20 minutes
Ultrasound signals database
The fetal heart activity is analyzed using mechanograms and Doppler during ultrasound (gold standard).
10 minutes
Secondary Outcomes (4)
Subject acceptability : Score
10 minutes
Subject Acceptability : Descriptive analysis
10 minutes
Use Error evaluation : System Usability Scale (SUS)
10 minutes
Use Error evaluation : Descriptive analysis
60 minutes
Study Arms (1)
Pregnancy volunteer subjects
EXPERIMENTALSubjects who will agree to participate in the study will be pregnant women referred to the Grenoble Alpes University Hospital for expert fetal cardiac ultrasound examination who have not revealed any abnormalities.
Interventions
The ECG - PCG signals are acquired over a 20-minute monitoring phase with passive non invasive sensors (abdominal and thoracic). The volunteer's abdomen is photographed when the electrodes and sensors are installed. An ultrasonography is also performed for 10 minutes. The session is filmed for 5 volunteers accepting the video. Any distinctive elements will be removed from photos and videos to prevent the identification of participants.
Eligibility Criteria
You may qualify if:
- single pregnancy
- between 20 and 26 weeks of amenorrhea
- with a BMI between 18.5 and 30 at the beginning of pregnancy
- fetal heart considered normal after expert ultrasound
- examination conditions deemed correct by the expert
- registered in a social security scheme
- having signed the study consent form
You may not qualify if:
- subject to a legal protection measure or unable to express consent (guardianship, guardianship) (article L1121-8)
- deprived of liberty by judicial or administrative decision (article L1121-6)
- with toxic consumption (i.e. tobacco, alcohol, cannabis)
- Intrauterine growth retardation (estimated fetal weight less than the 10th percentile)
- fetal heart rhythm disorders
- with unclear pregnancy term
- with pregnancy denial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Grenoblelead
- TIMC-IMAGcollaborator
- University Grenoble Alpscollaborator
- Clinical Investigation Centre for Innovative Technology Networkcollaborator
Study Sites (1)
University Hospital Grenoble Alpes
Grenoble, 38043, France
Related Publications (2)
Noorzadeh S, Rivet B, Gumery PY. An application of Gaussian processes on ocular artifact removal from EEG. Annu Int Conf IEEE Eng Med Biol Soc. 2015 Aug;2015:554-7. doi: 10.1109/EMBC.2015.7318422.
PMID: 26736322BACKGROUNDNoorzadeh S, Niknazar M, Rivet B, Fontecave-Jallon J, Gumery PY, Jutten C. Modeling quasi-periodic signals by a non-parametric model: application on fetal ECG extraction. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:1889-92. doi: 10.1109/EMBC.2014.6943979.
PMID: 25570347BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias LACHUAD, MD
University Hospital Grenoble Alpes
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2020
First Posted
January 21, 2020
Study Start
August 31, 2020
Primary Completion
January 1, 2022
Study Completion
October 1, 2022
Last Updated
September 23, 2020
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share